Product logins

Find logins to all Clarivate products below.


Pain Management Devices – Market Insights – Europe (Supplemental)

The European pain management space remains active, with manufacturers continuing to innovate and work toward receiving regulatory approval for new indications, supporting market growth in Europe. Additionally, the prevalence of chronic pain is increasing, which will further support market growth. However, the European healthcare system remains constrained, and hence the European pain management device market is expected to see moderate growth through 2033.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for pain management devices in Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Aesthetic Energy-Based Devices – Market Insights – United States
Aesthetic energy-based device procedure volumes will be supported by the trend toward minimally invasive and noninvasive treatments. As a result, companies are investing in developing such devices…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Diagnostic Imaging Systems – Market Insights – China
The diagnostic imaging system market in China will see moderate growth in the overall diagnostic imaging space through 2034, driven by favorable demographic trends and the accelerating adoption of…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…